Esteve-Comas M - Search Results

1

Development of antinuclear antibodies and its clinical impact in patients with Crohn's disease treated with chimeric monoclonal anti-TNFalpha antibodies (infliximab).

Garcia-Planella E, Domènech E, Esteve-Comas M, Bernal I, Cabré E, Boix J, Gassull MA. Garcia-Planella E, et al. Eur J Gastroenterol Hepatol. 2003 Apr;15(4):351-4. doi: 10.1097/00042737-200304000-00003. Eur J Gastroenterol Hepatol. 2003. PMID: 12655253

2

[Azathioprine and mesalazine in the prevention of postsurgical recurrence of Crohn's disease: a retrospective study].

Domènech E, Scala L, Bernal I, García-Planella E, Casalots A, Piñol M, Esteve-Comas M, Cabré E, Boix J, Gassull MA. Domènech E, et al. Gastroenterol Hepatol. 2004 Dec;27(10):563-7. doi: 10.1016/s0210-5705(03)70533-0. Gastroenterol Hepatol. 2004. PMID: 15574279 Spanish.

3

How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials.

Fernández-Banares F, Cabré E, Esteve-Comas M, Gassull MA. Fernández-Banares F, et al. JPEN J Parenter Enteral Nutr. 1995 Sep-Oct;19(5):356-64. doi: 10.1177/0148607195019005356. JPEN J Parenter Enteral Nutr. 1995. PMID: 8577011

4

Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis.

Fernández-Bañares F, Bertrán X, Esteve-Comas M, Cabré E, Menacho M, Humbert P, Planas R, Gassull MA. Fernández-Bañares F, et al. Am J Gastroenterol. 1996 Dec;91(12):2498-9. Am J Gastroenterol. 1996. PMID: 8946973

5

[Recommendations for the use of infliximab (Remicade) in Crohn's disease. GETECCU 2001].

Domènech E, Esteve-Comas M, Gomollón F, Hinojosa J, Obrador A, Panés J, Gassull MA; Grupo Español de Trabajo en Enfermedad de Crohn y Colitis Ulcerosa (GETECCU). Domènech E, et al. Gastroenterol Hepatol. 2002 Mar;25(3):162-9. doi: 10.1016/s0210-5705(02)79012-2. Gastroenterol Hepatol. 2002. PMID: 11864540 Spanish. No abstract available.

6

Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot study.

Domènech E, Hinojosa J, Esteve-Comas M, Gomollón F, Herrera JM, Bastida G, Obrador A, Ruiz R, Saro C, Gassull MA; Spanish Group for the Study of Crohn's Disease and Ulcerative Colitis (GETECCU). Domènech E, et al. Aliment Pharmacol Ther. 2004 Dec;20(11-12):1347-52. doi: 10.1111/j.1365-2036.2004.02288.x. Aliment Pharmacol Ther. 2004. PMID: 15606397 Free article.

7

Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease.

Esteve-Comas M, Núñez MC, Fernández-Bañares F, Abad-Lacruz A, Gil A, Cabré E, González-Huix F, Bertrán X, Gassull MA. Esteve-Comas M, et al. Gut. 1993 Oct;34(10):1370-3. doi: 10.1136/gut.34.10.1370. Gut. 1993. PMID: 8244103 Free PMC article.

8

Changes in mucosal fatty acid profile in inflammatorybowel disease and in experimental colitis: a common response to bowel inflammation.

Fernández-Bañares F, Esteve-Comas M, Mañé J, Navarro E, Bertrán X, Cabré E, Bartolí R, Boix J, Pastor C, Gassull MA. Fernández-Bañares F, et al. Clin Nutr. 1997 Aug;16(4):177-83. doi: 10.1016/s0261-5614(97)80003-9. Clin Nutr. 1997. PMID: 16844596

9

Factors associated with low values of biochemical vitamin parameters in healthy subjects.

Fernández-Bañares F, Giné JJ, Cabré E, Abad-Lacruz A, Esteve-Comas M, González-Huix F, Gassull MA. Fernández-Bañares F, et al. Int J Vitam Nutr Res. 1994;64(1):68-74. Int J Vitam Nutr Res. 1994. PMID: 8200752

10

Abnormal fatty acid status in patients with Crohn disease.

Esteve-Comas M, Gassull MA. Esteve-Comas M, et al. Am J Clin Nutr. 2001 Mar;73(3):661-2. doi: 10.1093/ajcn/73.3.661. Am J Clin Nutr. 2001. PMID: 11237956 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

29 results

Search Page